Genezen Laboratories, Inc. Announces Executive Appointments

Genezen Laboratories, Inc. announced the appointment of Susan D’Costa, Ph.D. as Chief Technology Officer (CTO) and Nicole O’Brien, Ph.D. as Chief Commercial Officer (CCO).

Susan D’Costa comes with over 25 years of experience in molecular virology. She has held leadership roles in gene and cell therapy at esteemed companies such as Florida Biologix, Brammer Bio, Thermo Fisher Scientific, and Alcyone Therapeutics.

Nicole O’Brien has extensive experience collaborating with innovators and has held senior commercial leadership positions at Thermo Fisher Scientific, Brammer Bio, and FujiFilm Diosynth.

Genezen Laboratories, Inc. is a biotechnology company dedicated to advancing gene and cell therapy solutions.